LB Pharmaceuticals Inc Common Stock ( LBRX) - Key Metrics
LBRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0 | -$1.71 | -$1.25 | -$1.26 |
| 2026Q1 | $0 | -$0.67 | -$0.82 | -$0.83 |
| 2025Q4 | $0 | -$0.45 | -$0.72 | -$0.72 |
| 2025Q3 | $0 | -$0.14 | -$0.13 | -$0.13 |
| 2025Q2 | $0 | -$20.27 | -$22.33 | -$22.29 |
LBRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -4.75 |
| 2026Q1 | 0% | -9.20 |
| 2025Q4 | 0% | -12.37 |
| 2025Q3 | 0% | -28.20 |
| 2025Q2 | 0% | -0.21 |
LBRX
Price: $47.49
52 week price:
Earnings Per Share: -5.10 USD
Exchange: NGM
Sector: Healthcare
Industry: Biotechnology
Market Capitalization: 1.5 billion